CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes

Jason S. Mitchell, Justin A. Spanier, Alexander J. Dwyer, Todd P. Knutson, Mohannad Alkhatib, Gina Qian, Matthew E. Weno, Yixin Chen, Zachary R. Shaheen, Christopher Tucker, Takashi Kangas, Milagros Silva Morales, Nubia Silva, Tsuneyasu Kaisho, Michael A. Farrar, Brian T. Fife